These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31298366)

  • 21. MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2.
    Song BF; Xu LZ; Jiang K; Cheng F
    Funct Integr Genomics; 2023 Mar; 23(2):80. PubMed ID: 36884182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MIR-138-5P inhibits the progression of prostate cancer by targeting FOXC1.
    Huang H; Xiong Y; Wu Z; He Y; Gao X; Zhou Z; Wang T
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1193. PubMed ID: 32107877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR‑4262 inhibits colon cancer cell proliferation via targeting of GALNT4.
    Qu JJ; Qu XY; Zhou DZ
    Mol Med Rep; 2017 Oct; 16(4):3731-3736. PubMed ID: 28731150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1.
    Zhang X; Jin K; Luo JD; Liu B; Xie LP
    Neoplasma; 2019 Sep; 66(5):704-716. PubMed ID: 31129966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
    Song Y; Shao L; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Shen S; Chen J; Li Z; Liu Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):248. PubMed ID: 31186064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
    Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
    Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis.
    Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
    Gene; 2019 Jul; 705():44-50. PubMed ID: 30981837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3.
    Meng FJ; Meng FM; Wu HX; Cao XF
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.
    Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J; Bian C; Wang H; Huang S; Wu D
    J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting
    Ramalho-Carvalho J; Gonçalves CS; Graça I; Bidarra D; Pereira-Silva E; Salta S; Godinho MI; Gomez A; Esteller M; Costa BM; Henrique R; Jerónimo C
    Clin Epigenetics; 2018; 10():40. PubMed ID: 29599847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.
    Jiang J; Liu Y; Zhao Y; Tian F; Wang G
    Technol Cancer Res Treat; 2019; 18():1533033819852990. PubMed ID: 31138034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer.
    Liu J; Quan Z; Gao Y; Wu X; Zheng Y
    Biochem Biophys Res Commun; 2021 Oct; 576():73-79. PubMed ID: 34482026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-5195-3p functions as a tumor suppressor in prostate cancer via targeting CCNL1.
    Zeng X; Hu Z; Shen Y; Wei X; Gan J; Liu Z
    Cell Mol Biol Lett; 2022 Mar; 27(1):25. PubMed ID: 35260070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.